Items where Author is "Hodgson, David"
Number of items: 16.
2025
  • Antibody responses against influenza A decline with successive years of annual influenza vaccination. (2025) Sullivan, Sheena G; Khvorov, Arseniy; Carolan, Louise; Dowson, Leslie; Hadiprodjo, A Jessica; Sánchez-Ovando, Stephany; Liu, Yi; Leung, Vivian KY; Hodgson, David; Blyth, Christopher C; Macnish, Marion; Cheng, Allen C; Haugenauer, Michelle; Clark, Julia; Dougherty, Sonia; Macartney, Kristine; Koirala, Archana; Khatami, Ameneh; Jadhav, Ajay; Marshall, Helen; Riley, Kathryn E; Wark, Peter AB; Delahunty, Catherine; Subbarao, Kanta; Kucharski, Adam J; Fox, Annette
    • 2024
  • Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom. (2024) Gebrecherkos, Yonas; Hodgson, David picture_as_pdf
  • Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination. (2024) Hodgson, David; Wilkins, Neil; van Leeuwen, Edwin; Watson, Conall H; Crofts, Jonathan; Flasche, Stefan; Jit, Mark; Atkins, Katherine E
  • Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study. (2024) Krauer, Fabienne; Guenther, Felix; Treskova-Schwarzbach, Marina; Schoenfeld, Viktoria; Koltai, Mihaly; Jit, Mark; Hodgson, David; Schneider, Udo; Wichmann, Ole; Harder, Thomas; Sandmann, Frank G; Flasche, Stefan
  • Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study. (2024) Russell, Timothy W; Townsley, Hermaleigh; Hellewell, Joel; Gahir, Joshua; Shawe-Taylor, Marianne; Greenwood, David; Hodgson, David; Hobbs, Agnieszka; Dowgier, Giulia; Penn, Rebecca; Sanderson, Theo; Stevenson-Leggett, Phoebe; Bazire, James; Harvey, Ruth; Fowler, Ashley S; Miah, Murad; Smith, Callie; Miranda, Mauro; Bawumia, Philip; Mears, Harriet V; Adams, Lorin; Hatipoglu, Emine; O'Reilly, Nicola; Warchal, Scott; Ambrose, Karen; Strange, Amy; Kelly, Gavin; Kjar, Svend; Papineni, Padmasayee; Corrah, Tumena; Gilson, Richard; Libri, Vincenzo; Kassiotis, George; Gamblin, Steve; Lewis, Nicola S; Williams, Bryan; Swanton, Charles; Gandhi, Sonia; Beale, Rupert; Wu, Mary Y; Bauer, David LV; Carr, Edward J; Wall, Emma C; Kucharski, Adam J
    • 2023
  • Vaccination of Older Adults Against Respiratory Syncytial Virus: The Final Pieces of the Puzzle. (2023) Atkins, Katherine E; Hodgson, David
  • A systematic review and meta-analysis of the effects of non-pharmacological interventions on quality of life in adults with multiple sclerosis. (2023) Gitman, Victor; Moss, Kasey; Hodgson, David
    • 2022
  • Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. (2022) Colton, Hayley; Hodgson, David; Hornsby, Hailey; Brown, Rebecca; Mckenzie, Joanne; Bradley, Kirsty L; James, Cameron; Lindsey, Benjamin B; Birch, Sarah; Marsh, Louise; Wood, Steven; Bayley, Martin; Dickson, Gary; James, David C; Nicklin, Martin J; Sayers, Jon R; Zafred, Domen; Rowland-Jones, Sarah L; Kudesia, Goura; Kucharski, Adam; CMMID COVID-19 Working Group; Darton, Thomas C; de Silva, Thushan I; Collini, Paul J
  • Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales. (2022) Hodgson, David; Koltai, Mihaly; Krauer, Fabienne; Flasche, Stefan; Jit, Mark; Atkins, Katherine E
  • Determinants of RSV epidemiology following suppression through pandemic contact restrictions. (2022) Koltai, Mihaly; Krauer, Fabienne; Hodgson, David; van Leeuwen, Edwin; Treskova-Schwarzbach, Marina; Jit, Mark; Flasche, Stefan
  • Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study. (2022) Li, Xiao; Hodgson, David; Flaig, Julien; Kieffer, Alexia; Herring, William L; Beyhaghi, Hadi; Willem, Lander; Jit, Mark; Bilcke, Joke; Beutels, Philippe; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Invest
    • 2021
  • The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant. (2021) Hodgson, David; Flasche, Stefan; Jit, Mark; Kucharski, Adam J; CMMID COVID-19 Working Group; Centre for Mathematical Modelling of Infectious Disease (CMMID)
  • Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study. (2021) Li, You; Hodgson, David; Wang, Xin; Atkins, Katherine E; Feikin, Daniel R; Nair, Harish
    • 2020
  • Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis. (2020) Hodgson, David; Pebody, Richard; Panovska-Griffiths, Jasmina; Baguelin, Marc; Atkins, Katherine E
    • 2019
  • Estimates for quality of life loss due to Respiratory Syncytial Virus. (2019) Hodgson, David; Atkins, Katherine E; Baguelin, Marc; Panovska-Griffiths, Jasmina; Thorrington, Dominic; van Hoek, Albert Jan; Zhao, Hongxin; Fragaszy, Ellen; Hayward, Andrew C; Pebody, Richard
    • 2017
  • Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis. (2017) Hodgson, David; Baguelin, Marc; van Leeuwen, Edwin; Panovska-Griffiths, Jasmina; Ramsay, Mary; Pebody, Richard; Atkins, Katherine E